Conclusion: the osmolality of diets varied over time and according to the concentration of thickener in human milk and the infant formula. However, the observed variation remained within the recommended parameters, indicating that rice cereal is a safe thickener for the feeding of infants presented with mild or moderate oropharyngeal dysphagia.RESUMO Objetivo: avaliar o efeito do agente espessante na osmolalidade do leite humano e da f órmula infantil em relação às concentrações e ao efeito do tempo. Métodos: foram realizados 6 ensaios para avaliar a osmolalidade, ao natural e com espessamento, da fórmula infantil, leite humano ordenhado cru e pasteurizado. O cereal de arroz foi usado como agente espessante (nas concentra ções de 2%, 3%, 5% e 7%). A osmolalidade foi aferida pelo ...
from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2Em1Zux
via IFTTT
Πέμπτη 13 Δεκεμβρίου 2018
Osmolality analysis of human milk and an infant formula with modified viscosity for use in infants with dysphagia
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Me...
-
Abstract Desmoplastic small round cell tumor (DSCRT) is a rare malignancy most often seen in the abdomen or pelvis of young men. Unfortuna...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nGQ2DC via IFTTT
-
Article content meets expectations Minimal relevance to assigned subject matter. Article content fails to meet all requirements Not Rubric f...
-
Objective To determine the association between neuroendocrine tumor (NET) biomarker levels and the extent of disease as assessed by 68 Ga DO...
-
Elementary school kids, on the other hand, can read, write, reason and think highly complex thoughts. Adele Faber and Elaine Mazlish, author...
-
by Mindaugas Paužuolis, Torsten Eich, Joachim Burman Background Natalizumab (NTZ) is a drug that has been widely used in the treatment of m...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου